No Data
No Data
A-share Lightning protection on July 15 | Tailin Bio: Gao De Investment intends to reduce its shareholding by no more than 1.67%; Chipbond Technology: expects to lose 0.439 billion yuan in the first half of the year.
Boji Medical Technology's controlling shareholder, the concerted action person, intends to reduce its shareholding by no more than 1.5%. Tailin Bio's shareholder, Gaode Investment, intends to reduce its shareholding by no more than 1.67%. Xilinx expects to lose 0.439 billion yuan in the first half of the year. Greentown Technology stated that the U.S. Commerce Department has initiated an anti-dumping and countervailing investigation into certain low-speed vehicles imported from China.
Tailin Biotech (300813.SZ) plans to pay 1 yuan for 10 shares to be deducted from interest on May 27
Tailin Biotech (300813.SZ) announced that the company's 2023 equity distribution plan: every 10 shares to all shareholders...
Optimistic Investors Push Zhejiang Tailin BioEngineering Co.,Ltd (SZSE:300813) Shares Up 42% But Growth Is Lacking
Zhejiang Tailin BioEngineering Co.,Ltd (SZSE:300813) shares have continued their recent momentum with a 42% gain in the last month alone. Longer-term shareholders would be thankful for the recovery
Tailin Biotech (300813.SZ): The subsidiary has no products in the manufacture of bio-based materials or synthetic materials
Gelonghui, May 9丨Tailin Biology (300813.SZ) said on the investor interactive platform that its subsidiary Tailin Medical Devices currently has no products in the manufacture of bio-based materials or synthetic materials.
Tailin Biotech (300813.SZ): The company has no medical equipment related to autologous stem cell regeneration insulin transplantation
Gelonghui, May 9丨Tailin Biotech (300813.SZ) said on the investor interactive platform that the company has no medical equipment related to autologous stem cell regeneration insulin transplantation.
Tailin Biology (300813.SZ): Currently, there is no direct layout in the direction of synthetic biology
On May 7, Gelonghui | Tailin Biotech (300813.SZ) said on the investor interactive platform that the company currently has no direct layout in the direction of synthetic biology.
No Data